292 related articles for article (PubMed ID: 22242854)
1. Current status of vitamin D signaling and its therapeutic applications.
Carlberg C; Molnar F
Curr Top Med Chem; 2012; 12(6):528-47. PubMed ID: 22242854
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor as a drug discovery target.
Pinette KV; Yee YK; Amegadzie BY; Nagpal S
Mini Rev Med Chem; 2003 May; 3(3):193-204. PubMed ID: 12570835
[TBL] [Abstract][Full Text] [Related]
3. The first genome-wide view of vitamin D receptor locations and their mechanistic implications.
Carlberg C; Seuter S; Heikkinen S
Anticancer Res; 2012 Jan; 32(1):271-82. PubMed ID: 22213316
[TBL] [Abstract][Full Text] [Related]
4. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands.
Carlberg C; Molnár F
Curr Top Med Chem; 2006; 6(12):1243-53. PubMed ID: 16848738
[TBL] [Abstract][Full Text] [Related]
5. Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3.
Norman AW; Okamura WH; Bishop JE; Henry HL
Mol Cell Endocrinol; 2002 Nov; 197(1-2):1-13. PubMed ID: 12431790
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view.
Carlberg C; Molnár F
Can J Physiol Pharmacol; 2015 May; 93(5):311-8. PubMed ID: 25741777
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor ligands: the impact of crystal structures.
Carlberg C; Molnár F; Mouriño A
Expert Opin Ther Pat; 2012 Apr; 22(4):417-35. PubMed ID: 22449247
[TBL] [Abstract][Full Text] [Related]
8. The importance of stereochemistry on the actions of vitamin D.
Chiellini G; DeLuca HF
Curr Top Med Chem; 2011; 11(7):840-59. PubMed ID: 21291397
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.
Haussler MR; Jurutka PW; Mizwicki M; Norman AW
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and Its Synthetic Analogs.
Maestro MA; Molnár F; Carlberg C
J Med Chem; 2019 Aug; 62(15):6854-6875. PubMed ID: 30916559
[TBL] [Abstract][Full Text] [Related]
11. Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice.
Boyan BD; Sylvia VL; McKinney N; Schwartz Z
J Cell Biochem; 2003 Dec; 90(6):1207-23. PubMed ID: 14635194
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
13. Noncalcemic actions of vitamin D receptor ligands.
Nagpal S; Na S; Rathnachalam R
Endocr Rev; 2005 Aug; 26(5):662-87. PubMed ID: 15798098
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of the selective activity of vitamin D analogues.
Carlberg C
J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
[TBL] [Abstract][Full Text] [Related]
15. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M; Makishima M
Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
[TBL] [Abstract][Full Text] [Related]
17. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor.
Carlberg C; Campbell MJ
Steroids; 2013 Feb; 78(2):127-36. PubMed ID: 23178257
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor ligands for osteoporosis.
Cheskis BJ; Freedman LP; Nagpal S
Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
[TBL] [Abstract][Full Text] [Related]
20. Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein.
Norman AW; Ishizuka S; Okamura WH
J Steroid Biochem Mol Biol; 2001; 76(1-5):49-59. PubMed ID: 11384863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
